Medirom Healthcare Technologies Free Cash Flow (FCF) History (MRM)
Medirom Healthcare Technologies reported −¥1.40B in free cash flow for fiscal 2024, a decrease of ¥635.5M from the previous fiscal year, with a free cash flow margin of −16.91%.
View full Medirom Healthcare Technologies company overviewMedirom Healthcare Technologies free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −¥1.40B | −¥635.5M | — | −16.91% |
| 2023 | 2023-12-31 | −¥767.6M | ¥38.9M | — | −11.24% |
| 2022 | 2022-12-31 | −¥806.4M | −¥153.6M | — | −11.60% |
| 2021 | 2021-12-31 | −¥652.9M | −¥212.9M | — | −12.07% |
| 2020 | 2020-12-31 | −¥440.0M | −¥440.4M | — | −13.17% |
| 2019 | 2019-12-31 | ¥464,000 | — | — | +0.01% |
Medirom Healthcare Technologies quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Medirom Healthcare Technologies free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from ¥464,000 to −¥1.40B, a net decrease of ¥1.40B.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Medirom Healthcare Technologies filings at SEC.gov ↗